128 Results for "

NF-κB/HIF-1α-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (128)

128 Results for "NF-κB/HIF-1α-IN-1" in MCE Product Catalog:

Cat. No.: HY-173488
Research Areas:  

Cancer

NF-κB/HIF-1α-IN-1 (compound 9c) is a potent blocker of the NF-κB activation pathway and demonstrates selective anti-fibrotic activity. NF-κB/HIF-1α-IN-1 shows no significant cytotoxicity in NCI tumor cell lines. In rat models. NF-κB/HIF-1α-IN-1 has been shown to effectively ameliorate liver fibrosis by inhibiting the expression levels of NF-κB and HIF-1α, while simultaneously inducing the activation of Nrf2 .
loading...
    loading...
66
66 Publications Verification
Cat. No.: HY-13671
CAS No.: 934593-90-5
Purity:  98.47%
Synonyms: HIF-1α inhibitor; LW8
Research Areas:  

Cancer

LW6 (HIF-1α inhibitor) is a novel HIF-1 inhibitor with an IC50 value of 4.4 μM, and it is also an inhibitor of MDH2. LW6 decreases HIF-1α protein expression without affecting HIF-1β expression.
loading...
    loading...
50
50 Cited Publications
Cat. No.: HY-100543
CAS No.: 72795-26-7
Purity:  99.60%
Synonyms: ICI-118551
Zenidolol (ICI-118551) is a selective β2-adrenergic receptor antagonist with Ki values of Zenidolol for β2, β1 and β3 adrenergic receptors of 0.7, 49.5 and 611 nM, respectively. Zenidolol exerts antitumor effects via inducing apoptosis, inhibiting tumor sphere formation, and downregulating the HIF pathway by blocking β2-AR on tumor cells. Zenidolol exhibits a unique pulmonary vessel-specific vasodilatory effect in mouse models. Zenidolol can be used as an intraocular pressure-lowering agent in ophthalmic disease research .
loading...
    loading...
22
22 Cited Publications
Cat. No.: HY-12519
CAS No.: 64224-21-1
Purity:  99.87%
Synonyms: RP 35972; NSC 347901
Research Areas:  

Cancer

Oltipraz has an inhibitory effect on HIF-1α activation in a time-dependent manner, completely abrogating HIF-1α induction at ≥10 μM concentrations, the IC50 of Oltipraz for HIF-1α inhibition is 10 μM. Oltipraz is a potent Nrf2 activator.
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-125840
CAS No.: 1672668-24-4
Purity:  99.85%
Synonyms: PT2977; MK-6482
Research Areas:  

Cancer

Belzutifan (PT2977) is an orally active and selective HIF-2α inhibitor with an IC50 of 9 nM. Belzutifan, as a second-generation HIF-2α inhibitor, increases potency and improves pharmacokinetic profile. Belzutifan is a potential treatment for clear cell renal cell carcinoma (ccRCC) .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-108697
CAS No.: 1672662-14-4
Purity:  99.90%
Research Areas:  

Cancer

PT2399 is a potent and selective HIF-2α antagonist, which directly binds to HIF-2α PAS B domain with an IC50 of 6 nM. PT2399 displays potent antitumor activity in vivo .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-P80704
Synonyms: HIF1A; BHLHE78; MOP1; PASD8; Hypoxia-inducible factor 1-alpha; HIF-1-alpha; HIF1-alpha; ARNT-interacting protein; Basic-helix-loop-helix-PAS protein MOP1; Class E basic helix-loop-helix protein 78; bHLHe78; Member of PAS protein 1; PAS doma

Host:  

Rabbit

Application:  

WB, ICC/IF, ELISA

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-110266
CAS No.: 1421448-26-1
Purity:  99.60%
Research Areas:  

Cancer

GN44028 is a potent and orally active hypoxia inducible factor (HIF)-1α inhibitor, with an IC50 of 14 nM. GN44028 inhibits hypoxia-induced HIF-1α transcriptional activity without suppressing HIF-1α mRNA expression, HIF-1α protein accumulation, or HIF-1α/HIF-1β heterodimerization. GN44028 can be used in the research of cancers .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-15641
CAS No.: 223387-75-5
Purity:  99.46%
Synonyms: IOX3; YM311
Research Areas:  

Metabolic Disease

FG-2216 (IOX3) is a potent and orally active inhibitor of HIF prolyl hydroxylase-2 (PHD2), with an IC50 of 3.9 μM. FG-2216 induces robust erythropoietin and modest fetal hemoglobin in vivo .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-115903
CAS No.: 2762315-06-8
Purity:  98.45%
Research Areas:  

Cancer

HIF-1α-IN-2 is an effective HIF-1α inhibitor with anticancer potencies (IC50s of 28 nM and 15 nM in MDA-MB-231 and MiaPaCa-2 cells, respectively). HIF-1α-IN-2 suppresses HIF-1α expression by blocking transcription and protein translation .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-115903A
Purity:  99.16%
Research Areas:  

Cancer

HIF-1α-IN-2 hydrochloride is an effective HIF-1α inhibitor with anticancer potencies (IC50s of 28 nM and 15 nM in MDA-MB-231 and MiaPaCa-2 cells, respectively). HIF-1α-IN-2 hydrochloride suppresses HIF-1α expression by blocking transcription and protein translation .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-P74888
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HIF1A; Basic-Helix-Loop-Helix-PAS Protein MOP1; Hypoxia Inducible Factor 1 Subunit Alpha; HIF-1-Alpha; BHLHe78; Hypoxia Inducible Factor 1 Alpha Subunit; PASD8; Hypoxia-Inducible Factor1alpha; MOP1; Member Of PAS Superfamily 1; Class E Basic Helix-Loop-Helix Protein 78; ARNT Interacting Protein; Hypoxia-Inducible Factor 1-Alpha; ARNT-Interacting Protein; PAS Domain-Containing Protein 8; HIF1-ALPHA; Member Of PAS Protein 1; HIF1-Alpha; HIF-1alpha; BHLHE78; HIF1; HIF-1A; Hypoxia Inducible Factor 1, Alpha Subunit (Basic Helix-Loop-Helix Transcription Factor)
Species:  
Human
Source:  
E. coli
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-103227
CAS No.: 1616690-16-4
Purity:  99.49%
Synonyms: ZYAN1
Research Areas:  

Cardiovascular Disease

Desidustat is an orally active HIF hydroxylase inhibitor. Desidustat can be used for the research of various disorders including anemia of different types and conditions associated with ischemia/hypoxia .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P1420
CAS No.: 1446322-66-2
Research Areas:  

Cancer

TAT-cyclo-CLLFVY is a cyclic peptide inhibitor of HIF-1 heterodimerization that inhibits hypoxia signaling in cancer cells. TAT-cyclo-CLLFVY disrupts HIF-1α/HIF-1β protein-protein interaction with an IC50 of 1.3 μM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-139287
CAS No.: 823830-85-9
Purity:  99.69%
Research Areas:  

Cancer

M1002 is a hypoxia-inducible factor-2 (HIF-2) agonist, and can enhance the expression of HIF-2 target genes. M1002 shows synergy with prolyl-hydroxylase domain (PHD) inhibitors .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-18371
CAS No.: 1422955-31-4
Research Areas:  

Inflammation/Immunology

TC-S 7009 is a potent and selective HIF-2α inhibitor with a Kd of 81 nM. TC-S 7009 is more selective for HIF-2α than HIF-1α (Kd ? 5 μM). TC-S 7009 disrupts HIF-2α heterodimerization, decreases DNA-binding activity, and reduces HIF-2α target gene expression .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19949
CAS No.: 1799948-06-3
Research Areas:  

Metabolic Disease

HIF-2α-IN-1 (compound 9b) is a HIF-2α inhibitor (IC50=1.7 μM, SPA/scintillation proximity assay) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-153016
CAS No.: 2750141-15-0
Purity:  99.59%
Research Areas:  

Inflammation/Immunology

HIF-2α agonist 2 (compound 10) is a HIF-2α agonist with an EC50 value of 1.68 μM at the dose of 20 μM. HIF-2α agonist 2 is non-cytotoxic against 786-O-HRE-Luc cells. HIF-2α agonist 2 can be used for oxygen metabolism research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-136748
CAS No.: 882268-69-1
Purity:  99.96%
Research Areas:  

Cancer

HIF-2α-IN-4 is a potent inhibitor of hypoxia inducible factor-2α (HIF-2α) translation, with an IC50 of 5 μM. HIF-2α-IN-4 decreases both constitutive and hypoxia-induced HIF-2α protein expression. HIF-2α-IN-4 links its 5'UTR iron-responsive element to oxygen sensing .
loading...
    loading...
Cat. No.: HY-153017
CAS No.: 333357-56-5
Purity:  99.50%
Research Areas:  

Cancer

HIF-1 inhibitor-4 is a HIF-1 inhibitor (IC50: 560 nM). HIF-1 inhibitor-4 reduces the HIF-1α protein level without affecting its mRNA level .
loading...
    loading...